CVE:ADK DIAGNOS (ADK) Stock Price, News & Analysis C$0.28 +0.02 (+5.56%) (As of 11/22/2024 05:18 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider Trades About DIAGNOS Stock (CVE:ADK) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DIAGNOS alerts:Sign Up Key Stats Today's RangeC$0.27▼C$0.2950-Day RangeC$0.26▼C$0.3852-Week RangeC$0.23▼C$0.57Volume159,800 shsAverage Volume92,571 shsMarket CapitalizationC$23.21 millionP/E RatioN/ADividend Yield0.29%Price TargetC$1.50Consensus RatingStrong Buy Company OverviewDIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.Read More… Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. DIAGNOS Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks24th Percentile Overall ScoreADK MarketRank™: DIAGNOS scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingStrong Buy Consensus RatingDIAGNOS has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageDIAGNOS has received no research coverage in the past 90 days.Read more about DIAGNOS's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of DIAGNOS is -7.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of DIAGNOS is -7.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about DIAGNOS's valuation and earnings. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for ADK. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldDIAGNOS has a dividend yield of 0.29%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthDIAGNOS does not have a long track record of dividend growth.Read more about DIAGNOS's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for ADK. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for DIAGNOS this week, compared to 0 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, DIAGNOS insiders have not sold or bought any company stock.Percentage Held by Insiders16.81% of the stock of DIAGNOS is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.01% of the stock of DIAGNOS is held by institutions.Read more about DIAGNOS's insider trading history. Receive ADK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter. Email Address ADK Stock News HeadlinesDIAGNOS Second Quarter 2025 Earnings: Revenues DisappointNovember 23 at 8:24 AM | finance.yahoo.comDIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock ExchangeNovember 12, 2024 | finance.yahoo.comTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.November 23, 2024 | Weiss Ratings (Ad)DIAGNOS Inc.: DIAGNOS Announces Voting Results of Meeting of ShareholdersOctober 1, 2024 | finanznachrichten.deADK:CA DIAGNOS Inc.September 21, 2024 | seekingalpha.comDIAGNOS First Quarter 2025 Earnings: EPS Beats Expectations, Revenues LagAugust 23, 2024 | finance.yahoo.comGot $1,000? 2 Stocks to Buy Now While They’re on SaleFebruary 23, 2024 | ca.finance.yahoo.comDIAGNOS recognized as a Top TSX Venture Exchange CompanyFebruary 21, 2024 | finance.yahoo.comSee More Headlines ADK Stock Analysis - Frequently Asked Questions How have ADK shares performed this year? DIAGNOS's stock was trading at C$0.41 at the start of the year. Since then, ADK stock has decreased by 29.6% and is now trading at C$0.29. View the best growth stocks for 2024 here. How do I buy shares of DIAGNOS? Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of DIAGNOS own? Based on aggregate information from My MarketBeat watchlists, some other companies that DIAGNOS investors own include DIAGNOS (DGNOF), Facedrive (FDVRF), New Found Gold (NFGC), Ackroo (AKR), BeWhere (BEW), BlueRush (BTV) and Grande West Transportation Group (BUS). Company Calendar Today11/23/2024Next Earnings (Estimated)11/26/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolCVE:ADK CUSIPN/A CIKN/A Webwww.diagnos.ca Phone+1-450-6788882FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price TargetC$1.50 High Stock Price TargetC$1.50 Low Stock Price TargetC$1.50 Potential Upside/Downside+426.3%Consensus RatingStrong Buy Rating Score (0-4)3.50 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-3,090,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-134.33% Debt Debt-to-Equity Ratio245.28 Current Ratio0.39 Quick Ratio0.68 Sales & Book Value Annual SalesC$577,486.00 Price / Sales40.19 Cash FlowC$0.00 per share Price / Cash Flow60.00 Book ValueC($0.03) per share Price / Book-9.50Miscellaneous Outstanding Shares81,440,000Free FloatN/AMarket CapC$23.21 million OptionableNot Optionable Beta-0.44 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (CVE:ADK) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DIAGNOS Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DIAGNOS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.